Sinopharm applies for vaccine market approval
Share - WeChat
Leading COVID-19 vaccine developer Sinopharm has submitted a market approval application to the top market regulator, according to media reports.
- Global experts praise China's plan for shared progress
- Remains of senior Chinese official Song Ping cremated
- Beijing-Pyongyang passenger rail service to resume Thursday
- Shanghai and Jiangsu integration boosts sports-tourism development
- China Eastern Airlines restores direct flights between Shanghai and Stockholm
- RedNote targets AI-run accounts with new governance rules































